Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Lew MF

Collect these papers and discover other ones on Labmeeting. Learn more.

Treatment Strategies and Quality-of-Care Indicators for Patients With Parkinson's Disease.

+ cite this

+ View Abstract

Chen JJ, Lew MF, and Siderowf A

Journal of managed care pharmacy : JMCP 15(3):1-22, 2009 Apr - Who cited this? | PubMed ID: 19267515 | Fulltext

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.

+ cite this

+ View Abstract

Hauser RA, Lew MF, Hurtig HI, Ondo WG, Wojcieszek J, Fitzer-Attas CJ, and TEMPO Open-label Study Group

Movement disorders : official journal of the Movement Disorder Society 24(4):564-73, 2009 Mar 15 - Who cited this? | PubMed ID: 19086083 | Fulltext

Complete ascertainment of Parkinson disease in the Swedish Twin Registry.

+ cite this

+ View Abstract

Wirdefeldt K, Gatz M, Bakaysa SL, Fiske A, Flensburg M, Petzinger GM, Widner H, Lew MF, Welsh M, and Pedersen NL

Neurobiology of aging 29(12):1765-73, 2008 Dec - Who cited this? | PubMed ID: 17532098 | Fulltext

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.

+ cite this

+ View Abstract

McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA,

(show remaining authors)

Movement disorders : official journal of the Movement Disorder Society 23(11):1596-601, 2008 Aug 15 - Who cited this? | PubMed ID: 18649400 | Fulltext

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

+ cite this

+ View Abstract

Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, Goldwurm S,

(show remaining authors)

Neurology 71(1):28-34, 2008 Jul 1 - Who cited this? | PubMed ID: 18509094 | Fulltext

Replication of association between ELAVL4 and Parkinson disease: the GenePD study.

+ cite this

+ View Abstract

Destefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, Singer C,

(show remaining authors)

Human genetics, 2008 Jun 29 - Who cited this? | PubMed ID: 18587682 | Fulltext

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.

+ cite this

+ View Abstract

Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C,

(show remaining authors)

BMC medicine 6:32, 2008 - Who cited this? | PubMed ID: 18986508 | Fulltext

Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease.

+ cite this

+ View Abstract

Lew MF, Pahwa R, Leehey M, Bertoni J, Kricorian G, and

Current medical research and opinion 23(4):741, 2007 Apr - Who cited this? | PubMed ID: 17407630 | Fulltext

Results from a 2-year centralized tolcapone liver enzyme monitoring program.

+ cite this

+ View Abstract

Lew MF and Kricorian G

Clinical neuropharmacology 30(5):281-6, 2007 - Who cited this? | PubMed ID: 17909306 | Fulltext

Calcification of the Basal Ganglia.

+ cite this

Hui JS and Lew MF

Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 84:479-86, 2007 - Who cited this? | PubMed ID: 18808965 | Fulltext

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.

+ cite this

+ View Abstract

Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, Prakash R,

(show remaining authors)

Neurology 67(12):2206-10, 2006 Dec 26 - Who cited this? | PubMed ID: 17190945 | Fulltext

Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.

+ cite this

+ View Abstract

Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, Saint-Hilaire MH,

(show remaining authors)

Archives of neurology 63(6):826-32, 2006 Jun - Who cited this? | PubMed ID: 16769863 | Fulltext

Selegiline orally disintegrating tablets for the treatment of Parkinson's disease.

+ cite this

+ View Abstract

Lew MF

Expert review of neurotherapeutics 5(6):705-12, 2005 Nov - Who cited this? | PubMed ID: 16274328 | Fulltext

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.

+ cite this

+ View Abstract

Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, and Sheean GL

Movement disorders : official journal of the Movement Disorder Society 20(7):783-91, 2005 Jul - Who cited this? | PubMed ID: 15736159 | Fulltext

Behavioral changes as side effects of medication treatment for Parkinson's disease.

+ cite this

Hui JS, Murdock GA, Chung JS, and Lew MF

Advances in neurology 96:114-29, 2005 - Who cited this? | PubMed ID: 16383216 | Fulltext

Duration of effectiveness of botulinum toxin type B in the treatment of cervical dystonia.

+ cite this

Lew MF

Advances in neurology 94:211-5, 2004 - Who cited this? | PubMed ID: 14509675 | Fulltext

PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study.

+ cite this

+ View Abstract

Destefano AL, Lew MF, Golbe LI, Mark MH, Lazzarini AM, Guttman M, Montgomery E, Waters CH, Singer C, Watts RL, Currie LJ, Wooten GF, Maher NE, Wilk JB, Sullivan KM, Slater KM,

(show remaining authors)

American journal of human genetics 70(5):1089, 2002 May - Who cited this? | PubMed ID: 11920285 | Fulltext

Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.

+ cite this

+ View Abstract

Lew MF

The Clinical journal of pain 18(6 Suppl):S142-6, 2002 - Who cited this? | PubMed ID: 12569961 | Fulltext

Botulinum toxin type B (Myobloc, NeuroBloc): a new choice in cervical dystonia.

+ cite this

+ View Abstract

Lew MF

Expert review of neurotherapeutics 1(2):143-52, 2001 Nov - Who cited this? | PubMed ID: 19811026 | Fulltext

Genome-wide scan for Parkinson's disease: the GenePD Study.

+ cite this

+ View Abstract

DeStefano AL, Golbe LI, Mark MH, Lazzarini AM, Maher NE, Saint-Hilaire M, Feldman RG, Guttman M, Watts RL, Suchowersky O, Lafontaine AL, Labelle N, Lew MF, Waters CH, Growdon JH, Singer C,

(show remaining authors)

Neurology 57(6):1124-6, 2001 Sep 25 - Who cited this? | PubMed ID: 11571351 | Fulltext

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.

+ cite this

+ View Abstract

Shoulson I, Penney J, McDermott M, Schwid S, Kayson E, Chase T, Fahn S, Greenamyre JT, Lang A, Siderowf A, Pearson N, Harrison M, Rost E, Colcher A, Lloyd M, Matthews M,

(show remaining authors)

Neurology 56(4):455-62, 2001 Feb 27 - Who cited this? | PubMed ID: 11222787 | Fulltext

Current and emerging treatments for cervical dystonia.

+ cite this

+ View Abstract

Factor SA, Lew MF, and Trosch RM

CNS spectrums 5(6 Suppl 5):S1-8, 2000 Jun - Who cited this? | PubMed ID: 18268461 | Fulltext

The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.

+ cite this

+ View Abstract

Lew MF, Brashear A, and Factor S

Neurology 55(12 Suppl 5):S29-35, 2000 - Who cited this? | PubMed ID: 11188982 | Fulltext

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.

+ cite this

+ View Abstract

Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O'Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, and Koller M

Neurology 53(7):1431-8, 1999 Oct 22 - Who cited this? | PubMed ID: 10534247 | Fulltext

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

+ cite this

+ View Abstract

Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, and Koller M

Neurology 53(7):1439-46, 1999 Oct 22 - Who cited this? | PubMed ID: 10534248 | Fulltext

Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III.

+ cite this

+ View Abstract

Adler CH, Singer C, O'Brien C, Hauser RA, Lew MF, Marek KL, Dorflinger E, Pedder S, Deptula D, and Yoo K

Archives of neurology 55(8):1089-95, 1998 Aug - Who cited this? | PubMed ID: 9708959 | Fulltext

Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.

+ cite this

+ View Abstract

Lew MF, Adornato BT, Duane DD, Dykstra DD, Factor SA, Massey JM, Brin MF, Jankovic J, Rodnitzky RL, Singer C, Swenson MR, Tarsy D, Murray JJ, Koller M, and Wallace JD

Neurology 49(3):701-7, 1997 Sep - Who cited this? | PubMed ID: 9305326 | Fulltext

Pallidotomy increases activity of motor association cortex in Parkinson's disease: a positron emission tomographic study.

+ cite this

+ View Abstract

Grafton ST, Waters C, Sutton J, Lew MF, and Couldwell W

Annals of neurology 37(6):776-83, 1995 Jun - Who cited this? | PubMed ID: 7778851 | Fulltext

Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease.

+ cite this

+ View Abstract

Sutton JP, Couldwell W, Lew MF, Mallory L, Grafton S, DeGiorgio C, Welsh M, Apuzzo ML, Ahmadi J, and Waters CH

Neurosurgery 36(6):1112-6; discussion 1116-7, 1995 Jun - Who cited this? | PubMed ID: 7643989 | Fulltext

Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).

+ cite this

+ View Abstract

Lew MF, Shindo M, Moskowitz CB, Wilhelmsen KC, Fahn S, and Waters CH

Movement disorders : official journal of the Movement Disorder Society 9(3):318-20, 1994 May - Who cited this? | PubMed ID: 8041372 | Fulltext

Clozapine treatment of parkinsonism with psychosis.

+ cite this

Lew MF and Waters CH

Journal of the American Geriatrics Society 41(6):669-71, 1993 Jun - Who cited this? | PubMed ID: 8505467 | Fulltext

Consciousness, coma, and the vegetative state: physical basis and definitional character.

+ cite this

De Giorgio CM and Lew MF

Issues in law & medicine 6(4):361-71, 1991 - Who cited this? | PubMed ID: 2037460 | Fulltext

Psychopharmacologic and clinical correlates of attention in chronic schizophrenia.

+ cite this

+ View Abstract

Strauss ME, Lew MF, Coyle JT, and Tune LE

The American journal of psychiatry 142(4):497-9, 1985 Apr - Who cited this? | PubMed ID: 3976926 | Fulltext

Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.

+ cite this

+ View Abstract

Tune LE, Strauss ME, Lew MF, Breitlinger E, and Coyle JT

The American journal of psychiatry 139(11):1460-2, 1982 Nov - Who cited this? | PubMed ID: 6127957 | Fulltext

Intracranial self-stimulation in 3-day-old rat pups.

+ cite this

+ View Abstract

Moran TH, Lew MF, and Blass EM

Science (New York, N.Y.) 214(4527):1366-8, 1981 Dec 18 - Who cited this? | PubMed ID: 6975999 | Fulltext

Search Google Scholar for Lew MF

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!